Human neural networks with sparse TDP-43 pathology reveal NPTX2 misregulation in ALS/FTLD
Marián Hruška-PlocháňiD, Katharina M. Betz, Silvia RonchiiD, Vera I. WiersmaiD, Zuzanna Maniecka, Eva‐Maria Hock, Florent LaferrièreiD, Sonu Sahadevan, Vanessa HoopiD, Igor DelvendahliD, Martina PanattaiD, Alexander van der BourgiD, Dáša BohačiakováiD, Karl FrontzekiD, Adriano AguzziiD, Tammaryn LashleyiD, Mark D. RobinsoniD, Theofanis KarayannisiD, Martin Mueller, Andreas R. HierlemanniD, Magdalini PolymenidouiD
Abstract
Human cellular models of neurodegeneration require reproducibility and longevity, which is necessary for simulating these age-dependent diseases. Such systems are particularly needed for TDP-43 proteinopathies1,2, which involve human-specific mechanisms3-6 that cannot be directly studied in animal models. To explore the emergence and consequences of TDP-43 pathologies, we generated iPSC-derived, colony morphology neural stem cells (iCoMoNSCs) via manual selection of neural precursors7. Single-cell transcriptomics (scRNA-seq) and comparison to independent NSCs8, showed that iCoMoNSCs are uniquely homogenous and self-renewing. Differentiated iCoMoNSCs formed a self-organized multicellular system consisting of synaptically connected and electrophysiologically active neurons, which matured into long-lived functional networks. Neuronal and glial maturation in iCoMoNSC-derived cultures was similar to that of cortical organoids9. Overexpression of wild-type TDP-43 in a minority of iCoMoNSC-derived neurons led to progressive fragmentation and aggregation, resulting in loss of function and neurotoxicity. scRNA-seq revealed a novel set of misregulated RNA targets coinciding in both TDP-43 overexpressing neurons and patient brains exhibiting loss of nuclear TDP-43. The strongest misregulated target encoded for the synaptic protein NPTX2, which was consistently misaccumulated in ALS and FTLD patient neurons with TDP-43 pathology. Our work directly links TDP-43 misregulation and NPTX2 accumulation, thereby highlighting a new pathway of neurotoxicity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 10
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid and Inducible Mislocalization of Endogenous TDP43 in a Novel Human Model of Amyotrophic Lateral Sclerosis
Johanna Ganssauge, Sophie Hawkins, … Akshay Bhinge·eLifePeer-reviewed·Jul 24, 2025
- Highly variable molecular signatures of TDP-43 loss of function are associated with nuclear pore complex injury in a population study of sporadic ALS patient iPSNs
Jeffrey D. Rothstein, Caroline Warlick, Alyssa N. Coyne·bioRxiv·Dec 12, 2023
- Molecular Visualization of Neuronal TDP43 Pathology In Situ
Amanda L. Erwin, Martin G. Fernandez, … Shyamal Mosalaganti·bioRxiv·Aug 19, 2024
- Cell-Type Specific Molecular and Functional Consequences of TDP-43 Loss-of-Function in Human Induced Neurons
Vera Gysin Filippa, Karsten Bach, … Marcos Romualdo Costa·bioRxiv·Jan 28, 2026
- Spinal cord extracts from sporadic ALS induce and propagate TDP-43 pathology in cerebral organoids
Yoshitaka Tamaki, Jay P. Ross, … Guy Armand Rouleau·PLoS GeneticsPeer-reviewed·Feb 6, 2023
- Mislocalisation of TDP-43 to the cytoplasm of either neurons or oligodendrocytes causes axonopathy and dysmyelination
Marcus Keatinge, Sandra Constantinou Juhasz, … Siddharthan Chandran·bioRxiv·Nov 17, 2025